The release of Semaglutide at a 45mg strength represents a significant development in treating diabetes. Previously, reduced doses were usually used, but this latest formulation offers the potential for more effective glucose control in certain patients. Clinicians are examining its effectiveness and safety profile, specifically in individuals w… Read More